Florentin Späth

9PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMedical mycologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 29, 2025
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

P Martijn Kolijn, Karl Smith-Byrne, Vernon Burk

|Mar 28, 2025
Prediagnostic Serum Immune Marker Levels and Multiple Myeloma: A Prospective Longitudinal Study Using Samples from the Janus Serum Bank in Norway.

Simona Herdenberg, Carl Wibom, Esmeralda J M Krop

|Aug 20, 2024
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance.

Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold

|Feb 24, 2022
Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients.

Widad Tahiru, Antonio Izarra Santamaria, Johan Hultdin

|Oct 18, 2021
High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.

P Martijn Kolijn, Fatemeh Saberi Hosnijeh, Florentin Späth

|Aug 24, 2021
Intraindividual Long-term Immune Marker Stability in Plasma Samples Collected in Median 9.4 Years Apart in 304 Adult Cancer-free Individuals.

Florentin Späth, Wendy Yi-Ying Wu, Esmeralda J M Krop

Pageof 2